CAS No. 1642288-47-8
Batch:
Purity:99.92
Chemical Structure
Check the
MYK-461 (Mavacamten)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione | |
|---|---|---|
| CAS Number | 1642288-47-8 | |
| Molecular Formula |
C15H19N3O2 |
|
| Molecular Weight (MW) | 273.33 | |
| SMILES | CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2 | |
| InChIKey | RLCLASQCAPXVLM-NSHDSACASA-N |
Mavacamten (MYK-461) is an oral, selective allosteric inhibitor of cardiac myosin ATPase that directly targets sarcomere hypercontractility. By inhibiting myosin ATPase, it reduces actin-myosin cross-bridge formation, leading to decreased cardiac muscle contractility and myocardial oxygen demand. In preclinical models of hypertrophic cardiomyopathy, Mavacamten attenuates sarcomere hypercontractility, improves ventricular compliance, and prevents the development of cardiac hypertrophy and myocardial fibrosis. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
55 mg/mL
(201.22 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 5 mg/mL |
| Water | Insoluble |
| DMSO |
27 mg/mL
(98.78 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 13 mg/mL |
| Water | Insoluble |
| DMSO |
55 mg/mL
(201.22 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 14 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- MYK-461 (Mavacamten) Clinical Trials
- MYK-461 (Mavacamten) Solubility in DMSO
- MYK-461 (Mavacamten) Stock Solution
- MYK-461 (Mavacamten) Storage
- MYK-461 (Mavacamten) Stability
- MYK-461 (Mavacamten) Molecular Weight
- MYK-461 (Mavacamten) SMILES
- MYK-461 (Mavacamten) Chemical Structure (2D and 3D)
- MYK-461 (Mavacamten) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.